Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Posts by Yin, Jiale

Home » Archives for Yin, Jiale » Archives for Yin, Jiale
About Yin, Jiale
Unlocking the Cure: A Groundbreaking Study on ENKTCL Treatment Success Rates and Implications

Unlocking the Cure: A Groundbreaking Study on ENKTCL Treatment Success Rates and Implications

Posted by By Yin, Jiale 2024.02.07
In September 2023, a retrospective multicentric study led by Professor Jun Zhu  from Peking University Cancer Hospital and Institute was published in the prestigious international academic journal ——Haematologica (IF=11.047). The title of the study…
Read More
Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever

Posted by By Yin, Jiale 2024.01.26
Editor's Note: At the recently held Fourth China Hematology Development Conference, the "Chinese Expert Consensus on the Application of Metagenomic Next-Generation Sequencing (mNGS) in the Diagnosis of Infectious Pathogens in…
Read More
Multidisciplinary Perspective: Professor MingGui Wang  Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

Multidisciplinary Perspective: Professor MingGui Wang  Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment

Posted by By Yin, Jiale 2024.01.26
Editor's Note: In recent years, the problem of drug resistance has intensified, and carbapenem-resistant organisms (CRO), representing multiple drug-resistant bacteria, have imposed a significant disease burden globally. Patients with blood diseases…
Read More
Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed

Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed

Posted by By Yin, Jiale 2024.01.26
On January 7th, the Fourth Chinese Hematology Development Conference unveiled the "Top 10 Research Advances in Chinese Hematology in 2023." The selection of the "Top 10 Research Advances in Chinese…
Read More
2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science

2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science

Posted by By Yin, Jiale 2024.01.26
The diagnosis of hematologic diseases has transitioned from traditional morphology-based methods to molecular diagnostics. Simultaneously, the treatment of these diseases has also moved from traditional chemotherapy to precision therapy, particularly…
Read More
2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL

2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL

Posted by By Yin, Jiale 2024.01.26
Children with Acute Lymphoblastic Leukemia (ALL) have a five-year overall survival (OS) rate exceeding 90%, but about 20% still experience disease relapse. Treating these relapsed or refractory ALL cases is…
Read More
2024 CASH丨Professor RongFu  : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy

2024 CASH丨Professor RongFu  : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy

Posted by By Yin, Jiale 2024.01.26
Immunotherapy has recently emerged as a focal area in the research of hematologic oncology. The advancement of genetic engineering and molecular biology, coupled with deeper insights into the mechanisms of…
Read More
2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized

2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized

Posted by By Yin, Jiale 2024.01.26
From January 5th to 7th, 2024, the Fourth China Hematology Development Conference (CASH) was grandly held in Tianjin. Continuing the theme of "Big Hematology, Big Health, Big Healthcare," the conference…
Read More
2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

Posted by By Yin, Jiale 2024.01.26
From January 5th to 7th, 2024, the 4th China/Academy of Hematology Sciences Development Conference (CASH) was grandly held in Tianjin. Continuing with the theme "Comprehensive Hematology, Healthcare, and Wellness", this…
Read More
2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

Posted by By Yin, Jiale 2024.01.26
β-thalassemia is a hereditary blood disorder caused by mutations in the β-globin gene, leading to impaired synthesis or structural changes in β-globin. Gene therapy for β-thalassemia using lentiviral vectors refers…
Read More

Posts pagination

Previous page 1 … 9 10 11 12 13 Next page
Recent Posts
  • World Hepatitis Day 2025 | Prof. George Lau: Exploring Optimal Strategies for HBV Antiviral Therapy from an Economic Perspective
  • APASL 2025 Expert Interview | Prof. George Lau: Dilemmas and Breakthroughs in Clinical Cure of Chronic Hepatitis B and Liver Cancer Prevention
  • China-Led International Real-World Study: TACE Plus Immunotherapy Boosts Survival Beyond 26 Months in Unresectable HCC
  • ILCA Roundtable | MDT: Optimizing HCC Treatment Strategies – Insights from the TALENT Series Studies
  • Prof. Qiang Wei: Gathering Global Expertise to Shape a New Landscape in Uro-Oncology at the West China Tianfu Academic Conference
Recent Comments
    Archives
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top